Clinical Trials Browser

Has results × Prostatic Neoplasms, Castration-Resistant × enzalutamide × Clear all

NCT05968599 2026-02-25

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Completed

2,731 enrolled 14 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT05551117 2026-02-09

Tamarack

Phase 2 Terminated

192 enrolled 20 charts

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Prostatic Neoplasms, Castration-Resistant

NCT02204072 2025-07-15

BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)

Phase 1 Completed

120 enrolled 28 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT05520138 2024-09-27

Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)

Completed

5,506 enrolled 11 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT03016312 2024-08-09

IMbassador250

Phase 3 Completed

759 enrolled 22 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant

NCT04157088 2023-08-04

DaroAcT

Phase 2 Terminated

30 enrolled 25 charts

Genitourinary

Prostatic Neoplasms, Castration-Resistant